(RTTNews) - Exact Sciences Corp. (EXAS), Friday announced the landmark clinical results from its ALTUS study, showing that the Oncoguard Liver blood test significantly outperforms ultrasound in ...

ALTUS study is the largest prospective trial of a blood test for liver cancer surveillance in the United States, reflecting the racial and ethnic diversity of high-risk groups Exact Sciences Corp.

Cirrhosis and liver cancer are two of the world’s leading causes of illness and death, but they typically creep up quietly. Most people with liver disease are symptom-free until complications like ...

Cancer of the liver, seen in a radial cross-section abdominal scan. (Photo by: BSIP/Universal Images Group via Getty Images) The number of new liver cancer cases will nearly double in the next 25 ...

Researchers in Sweden and Finland have created the CORE model, a simple blood test that predicts liver disease risk with striking accuracy. Unlike current methods, it works for the general population ...

A new study from Karolinska Institutet, published in the scientific journal The BMJ, shows how a simple blood analysis can predict the risk of developing severe liver disease. The method may already ...